Oxbridge Highlights Strong 2025–26 Performance, Platform Expansion, and Market Opportunity; Reports Q4 and Full-Year Results
Rhea-AI Summary
Oxbridge (NASDAQ: OXBR) reported Q4 and full-year results for 2025, highlighting strong tokenized reinsurance performance, platform expansion, and a $6.98M restricted cash position as of December 31, 2025.
Balanced Yield Token is tracking 25% vs 20% target; High Yield Token remains on track for 42%. Company expanded distribution into Solana and across 160+ blockchain networks and prepares T20/T42 offerings for 2026–2027.
Positive
- Balanced Yield Token tracking 25% return (vs 20% target)
- High Yield Token on track for 42% target
- Restricted cash increased to $6.98M as of Dec 31, 2025
- Platform distribution expanded into Solana and 160+ blockchain networks
Negative
- Total expenses rose to $6.04M in 2025 from $2.17M in 2024
- Loss ratio increased to 119.9% for year ended Dec 31, 2025
- Combined ratio rose to 264.1% for year ended Dec 31, 2025
- Net loss for 2025 was $2.08M (loss per share $0.28)
News Market Reaction – OXBRW
On the day this news was published, OXBRW gained 1.03%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
While OXBRW was down 1.3%, core equity peer OXBR rose 2.65%, with other insurance names mixed (GLRE up 1.31%, RELI down 9.83%, MACIW down 12.79%), pointing to stock-specific warrant dynamics rather than a clear sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 20 | Earnings call notice | Neutral | -1.3% | Announcement of date and time for Q4 and full-year results call. |
| Mar 12 | Distribution expansion | Positive | -3.8% | LayerZero and Alphaledger integration expanding tokens to 160+ blockchains. |
| Mar 12 | Distribution expansion | Positive | -3.8% | Details on T20/42 access and timelines via Alphaledger and LayerZero. |
| Feb 10 | New token offering | Positive | -12.7% | Launch of 2026–27 T20-2027 and T42-2027 tokenized reinsurance program. |
| Dec 11 | Solana partnership | Positive | -10.4% | Alphaledger partnership to bring high-yield tokenized reinsurance to Solana. |
Recent Oxbridge-related headlines, including product expansion and offering launches, have consistently coincided with negative price reactions despite neutral-to-positive messaging.
Over the past few months, Oxbridge and SurancePlus have focused on expanding tokenized reinsurance distribution and launching new T20/T42 offerings, often emphasizing targeted returns of 20% and 42% and broadening access across 160+ blockchain networks. However, prior news on these initiatives, as well as conference-call scheduling, saw 24-hour price moves from about -1.3% to -12.7%. Today’s detailed Q4 and full-year update fits this ongoing narrative of platform growth and token performance against a backdrop of weak warrant pricing.
Market Pulse Summary
This announcement details strong token performance, with the Balanced Yield Token tracking 25% against a 20% target and the High Yield Token on track for 42%, alongside expansion into the Solana ecosystem and 160+ networks. At the same time, 2025 results include a net loss of $2.08 million and a combined ratio of 264.1%. Investors may watch future loss ratios, expense trends, cash levels around $6.9 million, and adoption of new T20/T42 offerings as key metrics.
Key Terms
tokenized real-world assets financial
tokenized reinsurance financial
loss ratio financial
acquisition cost ratio financial
expense ratio financial
combined ratio financial
El Niño medical
restricted cash financial
AI-generated analysis. Not financial advice.
GRAND CAYMAN, Cayman Islands, March 30, 2026 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), a leader in digitizing reinsurance securities as tokenized real-world assets (RWAs), together with its subsidiary SurancePlus, today reported its results for the three months and year ended December 31, 2025.
SurancePlus 2025–2026 Tokenized Reinsurance Update
SurancePlus continues to demonstrate strong performance across its 2025–2026 tokenized reinsurance offerings. The Balanced Yield Token (EtaCat Re), which initially targeted a
Platform Expansion and Ecosystem Growth
The Company has advanced the SurancePlus platform through a series of strategic partnerships designed to expand global distribution, infrastructure, and interoperability:
- We have established a strategic presence in the Solana ecosystem through our partnership with Alphaledger, positioning SurancePlus within one of the leading blockchain platforms for real-world asset adoption, with support from ecosystem participants including the Solana Foundation.
- Formed a strategic collaboration with LayerZero, enabling distribution of SurancePlus offerings across more than 160 blockchain networks
In parallel, we have increased our targeted marketing and investor engagement initiatives, contributing to growing awareness and expanding participation.
Catastrophe Risk and 2026–2027 Outlook
The Company is preparing for the 2026–2027 contract cycle and its two tokenized reinsurance offerings, T20 and T42, which are targeting an annual return of
Strategic Outlook
We believe our current market valuation does not fully reflect the strength of our balance sheet, including our approximately
Management is also evaluating opportunities to expand the SurancePlus model into additional high-quality, cash-generating assets, including the potential tokenization of data centre revenue streams and other opportunities aligned with the growth of artificial intelligence infrastructure. These initiatives are intended to broaden the Company’s tokenization footprint and support long-term shareholder value creation.
Looking Ahead
The Company remains focused on scaling the SurancePlus platform, expanding global distribution, and executing on its growing pipeline of tokenized real-world asset opportunities.
With strong performance across its current offerings, expanding access through strategic partnerships, and continued innovation in product structure, the Company is well positioned to build on its momentum as it enters the 2026–2027 contract cycle.
Jay Madhu Chairman and CEO commented, “We are pleased with the continued strong performance of our RWA tokenized reinsurance platform, with our Balanced-Yield Token tracking
We have also made meaningful progress expanding our platform, including our entry into the Solana ecosystem and distribution across more than 160 blockchain networks. Looking ahead, we are excited about the upcoming year, including recent reporting from Artemis, indicating El Niño conditions may support a reality of storm numbers being around or even below historical averages.
In parallel, we are evaluating advanced opportunities to extend our model into additional high-quality, cash-generating assets, including the tokenization of data center revenues aligned with the growth of artificial intelligence. We also believe our current market valuation does not fully reflect the strength of our balance sheet, including our cash and restricted position, nor the opportunities we see to drive incremental shareholder value.”
Financial Performance
Net premiums earned for the three months ended December 31, 2025 decreased to
Net premiums earned for the years ended December 31, 2025 and 2024 was approximately
Net income for the quarter ended December 31, 2025 was
Net loss for the year ended December 31, 2025 was
For the three months ended December 31, 2025, total expenses, including policy acquisition costs and general and administrative expenses, increased to
For the year ended December 31, 2025, total expenses, including policy acquisition costs, loss and loss adjustment expenses and general and administrative expenses, increased to
As of December 31, 2025, our restricted cash and cash equivalents increased by
Financial Ratios
Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred to premiums earned and measures the underwriting profitability of our reinsurance business. The loss ratio increased to
Acquisition Cost Ratio. The acquisition cost ratio is the ratio of policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio measures our operational efficiency in producing, underwriting and administering our reinsurance business. The acquisition cost ratio remained consistent at
Expense Ratio. The expense ratio is the ratio of policy acquisition costs and general and administrative expenses to net premiums earned. We use the expense ratio to measure our operating performance. For the year ended December 31, 2025, the expense ratio increased to
Combined ratio. We use the combined ratio to measure our underwriting performance. The combined ratio is the sum of the loss ratio and the expense ratio. For the year ended December 31, 2025, the combined ratio increased to
Conference Call
Management will host a conference call later today to discuss these financial results, followed by a question and answer session. President and Chief Executive Officer Jay Madhu and Chief Financial Officer Wrendon Timothy will host the call starting at 4:30 p.m. Eastern time. The live presentation can be accessed by dialing the number below or by clicking the webcast link available on the Investor Information section of the company’s website at www.oxbridgere.com.
Date: March 30, 2026
Time: 4.30 p.m. Eastern time
Toll-free number: 877-524-8416
International number: +1 412-902-1028
Please call the conference telephone number 15 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact InComm Conferencing at +1-201-493-6280
media@incommconferencing.com
A replay of the call will be available by telephone after 4:30 p.m. Eastern time on the same day of the call until April 13, 2026.
Toll-free replay number: 877-660-6853
International replay number: +1-201-612-7415
Conference ID: 13759252
About Oxbridge Re Holdings Limited
Oxbridge Re Holdings Limited (www.OxbridgeRe.com) (NASDAQ: OXBR, OXBRW) (“Oxbridge Re”) is headquartered in the Cayman Islands. The company offers tokenized Real-World Assets (“RWAs”) as tokenized reinsurance securities and reinsurance business solutions to property and casualty insurers, through its wholly owned subsidiaries Oxbridge Reinsurance Limited, Oxbridge Re NS, and SurancePlus Inc.
Insurance businesses in the Gulf Coast region of the United States purchase property and casualty reinsurance through our licensed reinsurers Oxbridge Reinsurance Limited and Oxbridge Re NS.
Our new Web3-focused subsidiary, SurancePlus Inc. (“SurancePlus”), has developed the first “on-chain” reinsurance RWA of its kind to be sponsored by a subsidiary of a publicly traded company. By digitizing interests in reinsurance contracts as on-chain RWAs, SurancePlus has democratized the availability of reinsurance as an alternative investment to both U.S. and non-U.S. investors.
Forward-Looking Statements
This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project” and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on 30th March 2026. The occurrence of any of these risks and uncertainties could have a material adverse effect on the Company’s business, financial condition and results of operations. Any forward-looking statements made in this press release speak only as of the date of this press release and, except as required by law, the Company undertakes no obligation to update any forward-looking statement contained in this press release, even if the Company’s expectations or any related events, conditions or circumstances change.
Company Contact:
Oxbridge Re Holdings Limited
Jay Madhu, CEO
345-749-7570
jmadhu@oxbridgere.com
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(expressed in thousands of U.S. Dollars, except per share and share amounts)
| At December 31, | ||||||||
| 2025 | 2024 | |||||||
| Assets | ||||||||
| Investments: | ||||||||
| Equity securities, at fair value (cost: | - | 113 | ||||||
| Cash and cash equivalents | 268 | 2,135 | ||||||
| Restricted cash and cash equivalents | 6,708 | 3,758 | ||||||
| Premiums receivable | 766 | 1,059 | ||||||
| Other investments | - | 48 | ||||||
| Deferred policy acquisition costs | 102 | 109 | ||||||
| Operating lease right-of-use assets | 43 | 148 | ||||||
| Prepayment and other assets | 150 | 94 | ||||||
| Property and equipment, net | 16 | 1 | ||||||
| Total assets | $ | 8,053 | 7,465 | |||||
| Liabilities and Shareholders’ Equity | ||||||||
| Liabilities: | ||||||||
| Reserve for losses and loss adjustment expenses | 91 | - | ||||||
| Notes payable to noteholders | 118 | 118 | ||||||
| Losses payable | 73 | - | ||||||
| Unearned premiums reserve | 926 | 991 | ||||||
| Operating lease liabilities | 43 | 148 | ||||||
| Accounts payable and other liabilities | 309 | 366 | ||||||
| Total liabilities | 1,560 | 1,623 | ||||||
| Mezzanine Equity | ||||||||
| Due to EpsilonCat Re / DeltaCat Re / EtaCat Re / ZetaCat Re Tokenholders | 518 | 1732 | ||||||
| Shareholders’ equity: | ||||||||
| Ordinary share capital, (par value | 6 | 6 | ||||||
| Additional paid-in capital | 38,047 | 34,105 | ||||||
| Accumulated Deficit | (32,137 | ) | (30,163 | ) | ||||
| Total Oxbridge shareholders’ equity | 5,916 | 3,948 | ||||||
| Non-controlling interests | 59 | 162.00 | ||||||
| Total shareholders’ equity | 5,975 | 4,110 | ||||||
| Total liabilities, mezzanine and shareholders’ equity | 8,053 | 7,465 | ||||||
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
(expressed in thousands of U.S. Dollars, except per share amounts)
| Three Months Ended | Year Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenue | ||||||||||||||||
| Assumed premiums | 53 | - | 2,275 | 2,379 | ||||||||||||
| Change in unearned premiums reserve | 502 | 595 | 12 | (76 | ) | |||||||||||
| Net premiums earned | 555 | 595 | 2,287 | 2,303 | ||||||||||||
| SurancePlus fee income | - | - | 1 | 312 | ||||||||||||
| Net investment and other income | 63 | 60 | 314 | 248 | ||||||||||||
| Realized gain on other investments | 35 | - | ||||||||||||||
| Interest and gain on redemption of Series A-1 preferred shares | - | 47 | - | 47 | ||||||||||||
| Interest and gain on redemption of loan receivable | - | - | - | 41 | ||||||||||||
| Unrealized loss on other investments | - | (208 | ) | (20 | ) | (2,145 | ) | |||||||||
| Change in fair value of equity securities | (42 | ) | (72 | ) | (40 | ) | (260 | ) | ||||||||
| Total revenue | $ | 576 | 422 | $ | 2,577 | 546 | ||||||||||
| Expenses | ||||||||||||||||
| Losses and loss adjustment expenses | 449 | - | 2,742 | - | ||||||||||||
| Policy acquisition costs and underwriting expenses | 61 | 66 | 252 | 254 | ||||||||||||
| General and administrative expenses | 531 | 431 | 3,046 | 1,917 | ||||||||||||
| Total expenses | $ | 1,041 | 497 | $ | 6,040 | 2,171 | ||||||||||
| Loss before loss (income) attributable to tokenholders and non-controlling interests | (465 | ) | (75 | ) | (3,463 | ) | (1,625 | ) | ||||||||
| Loss (income) attributable to tokenholders | 689 | (246 | ) | 1,386 | (962 | ) | ||||||||||
| Income (loss) before income attributable to non-controlling interests | 224 | (321 | ) | (2,077 | ) | (2,587 | ) | |||||||||
| Income attributable to non-controlling interests | (104 | ) | (139 | ) | (2 | ) | (139 | ) | ||||||||
| Net income (loss) attributable to ordinary shareholders | 120 | (460 | ) | (2,079 | ) | (2,726 | ) | |||||||||
| Loss per share attributable to ordinary shareholders | ||||||||||||||||
| Basic and Diluted | 0.02 | (0.05 | ) | (0.28 | ) | (0.45 | ) | |||||||||
| Weighted-average shares outstanding | ||||||||||||||||
| Basic and Diluted | 7,664,122 | 6,121,020 | 7,389,822 | 6,099,051 | ||||||||||||
| Performance ratios to net premiums earned: | ||||||||||||||||
| Loss ratio | 80.9 | % | 0.0 | % | 119.9 | % | 0.0 | % | ||||||||
| Acquisition cost ratio | 11.0 | % | 11.1 | % | 11.0 | % | 11.0 | % | ||||||||
| Expense ratio | 106.7 | % | 83.5 | % | 144.2 | % | 94.3 | % | ||||||||
| Combined ratio | 187.6 | % | 83.5 | % | 264.1 | % | 94.3 | % | ||||||||
